82 related articles for article (PubMed ID: 26685854)
1. Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing's sarcoma.
Moricoli D; Carbonella DC; Dominici S; Fiori V; Balducci MC; Guerzoni C; Manara MC; Pasello M; Laguardia ME; Cianfriglia M; Scotlandi K; Magnani M
Appl Microbiol Biotechnol; 2016 May; 100(9):3949-63. PubMed ID: 26685854
[TBL] [Abstract][Full Text] [Related]
2. CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
Guerzoni C; Fiori V; Terracciano M; Manara MC; Moricoli D; Pasello M; Sciandra M; Nicoletti G; Gellini M; Dominici S; Chiodoni C; Fornasari PM; Lollini PL; Colombo MP; Picci P; Cianfriglia M; Magnani M; Scotlandi K
Clin Cancer Res; 2015 Jan; 21(1):146-56. PubMed ID: 25501132
[TBL] [Abstract][Full Text] [Related]
3. Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma.
Scotlandi K; Perdichizzi S; Bernard G; Nicoletti G; Nanni P; Lollini PL; Curti A; Manara MC; Benini S; Bernard A; Picci P
Eur J Cancer; 2006 Jan; 42(1):91-6. PubMed ID: 16326096
[TBL] [Abstract][Full Text] [Related]
4. [Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
Delaplace M; Mélard P; Perrinaud A; Goré C; Vergier B; Machet L
Ann Dermatol Venereol; 2011 May; 138(5):395-8. PubMed ID: 21570564
[TBL] [Abstract][Full Text] [Related]
5. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
Werner S; Mendoza A; Hilger RA; Erlacher M; Reichardt W; Lissat A; Konanz C; Uhl M; Niemeyer CM; Khanna C; Kontny U
Cancer Chemother Pharmacol; 2008 Jun; 62(1):19-31. PubMed ID: 17823799
[TBL] [Abstract][Full Text] [Related]
6. Ewing's sarcoma of bone.
Moore DD; Haydon RC
Cancer Treat Res; 2014; 162():93-115. PubMed ID: 25070232
[TBL] [Abstract][Full Text] [Related]
7. Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.
Gellini M; Ascione A; Flego M; Mallano A; Dupuis ML; Zamboni S; Terrinoni M; D'Alessio V; Manara MC; Scotlandi K; Picci P; Cianfriglia M
Curr Pharm Biotechnol; 2013; 14(4):449-63. PubMed ID: 22335486
[TBL] [Abstract][Full Text] [Related]
8. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
[TBL] [Abstract][Full Text] [Related]
9. siRNA associated with immunonanoparticles directed against cd99 antigen improves gene expression inhibition in vivo in Ewing's sarcoma.
Ramon AL; Bertrand JR; de Martimprey H; Bernard G; Ponchel G; Malvy C; Vauthier C
J Mol Recognit; 2013 Jul; 26(7):318-29. PubMed ID: 23657987
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma.
Benini S; Zuntini M; Manara MC; Cohen P; Nicoletti G; Nanni P; Oh Y; Picci P; Scotlandi K
Int J Cancer; 2006 Sep; 119(5):1039-46. PubMed ID: 16570284
[TBL] [Abstract][Full Text] [Related]
11. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
12. Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system.
Moricoli D; Muller WA; Carbonella DC; Balducci MC; Dominici S; Watson R; Fiori V; Weber E; Cianfriglia M; Scotlandi K; Magnani M
J Immunol Methods; 2014 Jun; 408():35-45. PubMed ID: 24798881
[TBL] [Abstract][Full Text] [Related]
13. Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells.
Sohn HW; Choi EY; Kim SH; Lee IS; Chung DH; Sung UA; Hwang DH; Cho SS; Jun BH; Jang JJ; Chi JG; Park SH
Am J Pathol; 1998 Dec; 153(6):1937-45. PubMed ID: 9846983
[TBL] [Abstract][Full Text] [Related]
14. CD99 engagement: an effective therapeutic strategy for Ewing tumors.
Scotlandi K; Baldini N; Cerisano V; Manara MC; Benini S; Serra M; Lollini PL; Nanni P; Nicoletti G; Bernard G; Bernard A; Picci P
Cancer Res; 2000 Sep; 60(18):5134-42. PubMed ID: 11016640
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies.
Mhawech-Fauceglia P; Herrmann F; Penetrante R; Beck A; Sait S; Block AM; Odunsi K; Fisher J; Balos L; Cheney RT
Histopathology; 2006 Dec; 49(6):569-75. PubMed ID: 17163841
[TBL] [Abstract][Full Text] [Related]
16. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
Peng W; Huang X; Yang D
Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
[TBL] [Abstract][Full Text] [Related]
18. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
19. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
[TBL] [Abstract][Full Text] [Related]
20. Picropodophyllin inhibits the growth of Ewing's sarcoma cells through the insulin‑like growth factor‑1 receptor/Akt signaling pathway.
Wu YT; Wang BJ; Miao SW; Gao JJ
Mol Med Rep; 2015 Nov; 12(5):7045-50. PubMed ID: 26323364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]